SyneuRx

SyneuRx is focused on developing breakthrough therapeutics for mental health disorders and infectious diseases, including treatments for schizophrenia, dementia, depression, and COVID-19

Biotech & Life Sciences

Sector

Seed

Stage

Biotechnology

Model

01Company Overview

SyneuRx is focused on developing breakthrough therapeutics for mental health disorders and infectious diseases, including treatments for schizophrenia, dementia, depression, and COVID-19.

02Backed By1 investor

TCTaiwania Capital→

03Similar Companies